Prostaglandin F2αReceptor (FP Receptor) Agonists Are Potent Adipose Differentiation Inhibitors for Primary Culture of Adipocyte Precursors in Defined Medium-Reference-Cited by-同舟云学术

Prostaglandin F2αReceptor (FP Receptor) Agonists Are Potent Adipose Differentiation Inhibitors for Primary Culture of Adipocyte Precursors in Defined Medium

Published:1997-04 Issue:1 Volume:233 Page:200-202
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Serrero Ginette,Lepak Nancy M.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference14 articles.

1. Prostaglandin F2α inhibits the differentiation of adipocyte precursors in primary culture

2. Paracrine regulation of adipose differentiation by arachidonate metabolites: prostaglandin F2 alpha inhibits early and late markers of differentiation in the adipogenic cell line 1246.

3. Inhibition of adipose differentiation by 9α, 11β-prostaglandin F2α

4. Potent luteolytic agents related to prostaglandin F2α

5. Trends in Autonomic Pharmacology;Coleman,1985

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Effects of a Selective EP2 Agonist, Omidenepag, and a Rho-Associated Coiled-Coil Containing Protein Kinase Inhibitor, Ripasudil, on Human Orbital Fibroblasts;Journal of Ocular Pharmacology and Therapeutics;2023-09-01

2. Prostaglandin D<sub>2</sub> and F<sub>2α</sub> as Regulators of Adipogenesis and Obesity;Biological and Pharmaceutical Bulletin;2022-08-01

3. Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?;Aesthetic Surgery Journal;2022-06-14

4. In Vivo Effects of Prostaglandin Analogues Application by Topical Drops or Retrobulbar Injections on the Orbital Fat of a Rat Model;Ocular Immunology and Inflammation;2022-01-26

5. The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting;Frontiers in Oncology;2022-01-19